Chronic GCs exposure enhances neurodegeneration in cortex and hippocampus.
Chronic GCs exposure decreases expression of GR and MAP2 in cortex and hippocampus.
Chronic GCs exposure increases expression of NLRP1 and ASC in cortex and hippocampus.
Chronic GCs exposure increases expression of IL-1β and IL-6 in cortex and hippocampus.
Chronic GCs exposure increases brain inflammation via NLRP1 inflammasome activation.